Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). American Bio Medica's share price for the quarter that ended in Mar. 2023 was $0.01763. American Bio Medica's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 48.10 Mil. Therefore, American Bio Medica's market cap for the quarter that ended in Mar. 2023 was $0.85 Mil.
American Bio Medica's quarterly market cap
declined
from Sep. 2022 ($0.91 Mil) to Dec. 2022 ($0.26 Mil) but then
increased
from Dec. 2022 ($0.26 Mil) to Mar. 2023 ($0.85 Mil).
American Bio Medica's annual market cap
declined
from Dec. 2020 ($4.90 Mil) to Dec. 2021 ($1.78 Mil) and
declined
from Dec. 2021 ($1.78 Mil) to Dec. 2022 ($0.26 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. American Bio Medica's Enterprise Value for Today is $0.11 Mil.
American Bio Medica Market Cap Historical Data
The historical data trend for American Bio Medica's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of American Bio Medica's Market Cap
For the Diagnostics & Research subindustry, American Bio Medica's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Bio Medica's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, American Bio Medica's Market Cap distribution charts can be found below:
* The bar in red indicates where American Bio Medica's Market Cap falls into.
American Bio Medica Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
American Bio Medica's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica (OTCPK:ABMC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
American Bio Medica Market Cap Related Terms
Thank you for viewing the detailed overview of American Bio Medica's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
American Bio Medica (American Bio Medica) Business Description
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMC has been successfully added to your 